Rovi
Laboratorios Farmacéuticos Rovi, S.A. is a leading Spanish pharmaceutical company engaged in the research, development, contract manufacturing, and commercialization of biological and small molecule medicines. As a member of the IBEX 35, the company operates on a global scale, particularly recognized for its leadership in the low-molecular-weight heparin (LMWH) market and its extensive contract development and manufacturing organization (CDMO) services. Headquartered in Madrid, Rovi maintains a strong industrial presence with multiple production facilities across the Madrid region and Granada. For international professionals, Rovi offers diverse opportunities in high-tech manufacturing, quality assurance, and engineering, notably gaining global prominence through its strategic partnership with Moderna for fill-finish vaccine production. The company frequently recruits for technical and scientific roles, providing a gateway into the European pharmaceutical sector.
Company History
Founded in 1946 in Madrid by the López-Belmonte family, Rovi began as a small laboratory. It evolved into a global pharmaceutical group, going public in 2007 and eventually joining the IBEX 35 index in 2021.
For International Professionals
- Operates major manufacturing sites in Madrid (Alcalá de Henares, San Sebastián de los Reyes) and Granada.
- Key global partner for Moderna, handling large-scale fill-finish operations for mRNA vaccines.
- Publicly traded on the Spanish IBEX 35 index, indicating high corporate stability and scale.
- Offers a wide range of 'Beca' (internship) programs, making it accessible for junior international talent and graduates.
- Focuses heavily on R&D and specialized manufacturing, requiring diverse technical profiles from engineering to microbiology.
Open Positions (63)
63 open positions